Toxic pulmonary edema causes clinic first aid. Causes and consequences of pulmonary edema: this knowledge can save a life
1996 0
Doctors of various specialties, especially those working in multidisciplinary hospitals, constantly observe the symptom complex of acute respiratory failure, the development of which can be due to a number of reasons. The dramatic nature of this clinical situation lies in the fact that it poses a direct threat to life. The patient may die within a short period of time from the moment of its occurrence. The outcome depends on the correctness and timeliness of assistance.
Of the many causes of acute respiratory failure (atelectasis and collapse of the lung, massive pleural effusion and pneumonia involving large areas of the lung parenchyma, asthmatic status, pulmonary embolism, etc.), pulmonary edema is most often detected - a pathological process in which excess fluid accumulates in the interstitium of the lung tissue, and later in the alveoli themselves.
Pulmonary edema can be based on various pathogenetic mechanisms, depending on which it is necessary to distinguish between two groups of pulmonary edema (Table 16).
Etiology and pathogenesis
Despite the unequal mechanisms of development of pulmonary edema, doctors often do not distinguish them by pathogenesis and carry out the same type of treatment of fundamentally different conditions, which adversely affects the fate of patients.The most common is pulmonary edema associated with a significant increase in hemodynamic (hydrostatic) pressure in the pulmonary capillaries due to a significant increase in diastolic pressure in the left ventricle (aortic heart disease, systemic hypertension, cardiosclerosis or cardiomyopathy, arrhythmia, hypervolemia due to the infusion of large amounts of fluid or renal failure) or the left atrium (mitral valve disease, left atrial myxoma).
In such cases, as a result of a significant increase in the pressure gradient, the fluid passes through the alveolar-capillary barrier. Since the permeability of the epithelium of the alveoli is lower than that of the endothelium of the pulmonary capillaries, widespread edema of the pulmonary interstitium develops at first and only later does intraalveolar extravasation occur. The ability of an intact vascular wall to retain blood proteins determines the accumulation of fluid with a low protein content in the alveoli.
Table 16. Main diseases (conditions) leading to the development of pulmonary edema
Pulmonary edema may be associated with an increase in the permeability of the alveolar-capillary membrane due to its damage. Such pulmonary edema is called toxic. In the literature, it is also referred to by the terms "shock lung", "non-coronary (non-cardiac) pulmonary edema", "adult respiratory distress syndrome (ARDS)".
Toxic pulmonary edema occurs when one or another damaging factor (substance, agent) directly affects the alveolar-capillary membrane. Such a substance can reach the alveolar-capillary membrane aerogenically by inhalation of toxic gases or fumes, or hematogenously with the blood stream (endotoxins, allergens, immune complexes, heroin, etc.). The pathogenetic mechanisms underlying this pathological condition depend on the disease (condition), on the basis of which ARDS develops.
Toxic pulmonary edema can occur when the endothelium of the pulmonary capillaries is directly exposed to toxic substances and allergens (immune complexes) that enter the bloodstream. The pathogenesis of ARDS in endotoxicoses has been studied in detail using the example of sepsis. In such cases, the most important role in the occurrence of toxic pulmonary edema is played by endotoxins, which have both a direct damaging effect on the endothelial cells of the pulmonary capillaries, and indirectly - due to the activation of mediator systems of the body.
Endotoxins interact with sensitive cells and cause them to release large amounts of histamine, serotonin and other vasoactive compounds. In connection with the active participation of the lungs in the metabolism of these substances (the so-called non-respiratory function of the lungs), pronounced changes occur in this organ.
Electron microscopy revealed that high concentrations of histamine are created in the area of alveolar capillaries, tissue basophils accumulate and degranulation occurs in them, which is accompanied by damage to both endothelial cells and type 1 pneumocytes.
In addition, under the influence of toxins, macrophages secrete the so-called tumor necrosis factor, which has a direct damaging effect on endothelial cells, causing pronounced disturbances in both their permeability and microcirculation. Of certain importance are various enzymes released during the massive breakdown of neutrophils: elastase, collagenase and non-specific proteases that destroy glycoproteins of the interstitium and the main membrane of cell walls.
As a result of all this, damage to the alveolar-capillary membrane occurs during sepsis, which is confirmed by the results of microscopic examination: edema of pneumocytes, microcirculation disorders in the alveolar capillaries with structural disorders in endothelial cells and signs of increased vascular permeability are detected in the lung tissue.
Similar in pathogenesis are toxic pulmonary edema in other endotoxicoses and infectious diseases (peritonitis, leptospirosis, meningococcal and non-clostridial anaerobic infections) and pancreatitis, although, perhaps, in the latter, the direct effect of proteases on the endothelial cells of the pulmonary capillaries is also of great importance.
The development of toxic pulmonary edema by inhalation of highly toxic substances in the form of their vapors and aerosols, as well as fumes, has been studied in most detail. These substances are deposited on the mucous membranes of the respiratory tract and lead to a violation of their integrity. The nature of the damage depends primarily on which part of the respiratory tract and lung tissue is affected, which is mainly related to the solubility of the chemical in lipids and water.
The development of toxic pulmonary edema is caused mainly by toxic substances that have a tropism for lipids (nitric oxide, ozone, phosgene, cadmium oxide, monochloromethane, etc.). They dissolve in the surfactant and easily diffuse through thin pneumocytes to the capillary endothelium, damaging them.
Substances that are highly soluble in water (ammonia, calcium oxide, hydrogen chloride and fluoride, formaldehyde, acetic acid, bromine, chlorine, chloropicrin, etc.) have a slightly different damaging effect. They dissolve in the bronchial secretion of the airways, exerting a pronounced irritating effect.
Clinically, this manifests itself in the form of laryngospasm, swelling of the vocal cords and toxic tracheobronchitis with a persistent painful cough up to reflex respiratory arrest. Only in the case of inhalation of very high concentrations of toxic substances, the alveolar-capillary barriers can also be involved in the pathological process.
With toxic pulmonary edema of different etiologies and pathogenesis, the same cycle of changes occurs in the lung tissue, causing the two-phase clinical symptoms of respiratory distress syndrome in adults. Thus, the wall of the pulmonary capillary responds to the impact of a damaging factor with metabolic and structural changes with an increase in its permeability and the release of plasma and blood cells into the interstitium, which leads to a significant thickening of the alveolar-capillary membrane.
As a result, the diffusion path of oxygen and carbon dioxide through the alveolar-capillary membrane is lengthened. First of all, the diffusion of oxygen through it suffers, as a result of which hypoxemia develops.
In parallel, occurring microcirculation disorders in the form of blood stasis in paralytically dilated pulmonary capillaries also significantly impair gas exchange. During this period, ARDS the patient begins to notice shortness of breath with increased respiration, as in a healthy person after exercise. During a physical examination, pathological changes in the lungs are usually not detected in cases where there is no independent pathological process in the lung tissue, only a diffuse enhancement of the pulmonary pattern due to the vascular component is detected during radiography, and a decrease in the partial pressure of oxygen in capillary blood (less than 80 mm Hg. Art.).
This stage of pulmonary edema is called interstitial. It is most common in pancreatitis, leptospirosis, severe allergic reactions, and some forms of sepsis, and can last from 2 to 12 hours. It is difficult to follow in ARDS caused by the inhalation of toxic substances and fumes, as well as in peritonitis and aspiration of acidic gastric contents.
In these cases, as well as with the progression of the pathological process in the lung tissue, gross changes in the microvasculature of the lungs occur with intravascular thrombosis, a sharp dilatation of blood vessels and a violation of lymph drainage through the septal and perivascular membranes, which leads to accumulation of fluid in the alveoli and blockage of the bronchioles. Due to damage to the vascular endothelium, large amounts of protein enter the alveolar cavity along with the liquid.
As a result of damage to type II pneumocytes (which is most pronounced in persons whose lungs were exposed to toxic gases and fumes), the synthesis of surfactant is disrupted and the alveoli collapse. All this leads to an even greater disruption of gas exchange in the lungs with the development of severe respiratory failure. Scattered wet rales appear above the lungs, breathing becomes bubbling, and an x-ray examination reveals a decrease in pneumatization of the lung tissue according to the "snow storm" type (intra-alveolar stage of pulmonary edema).
In contrast to hemodynamic pulmonary edema, copious, frothy, pink-colored sputum is rarely observed in adult respiratory distress syndrome. Damage to the mucous membrane opens the way for a bacterial infection, which, along with the accumulation of protein-rich fluid in the alveoli, contributes to the occurrence of purulent bronchitis and pneumonia. The most common causative agents of the inflammatory process are opportunistic microbes - Escherichia and Pseudomonas aeruginosa, Proteus, Klebsiella and Staphylococcus aureus.
Some features of the clinical course of toxic pulmonary edema in various diseases and conditions can be noted. With sepsis, leptospirosis, and a number of other infectious diseases, ARDS often occurs at the height of the development of infectious-toxic (septic) shock, significantly aggravating the already serious condition of the patient. Cases are described when allergic reactions to drugs (primarily to antibiotics) served as one of the factors in the development of ARDS in patients with endotoxicosis, including sepsis.
Toxic pulmonary edema can also be observed with a severe allergic reaction (primarily to drugs administered intravenously - plasma substitutes, antibiotics, etc.). In these cases, acute respiratory failure joins skin manifestations, hypotension, hyperthermia, but it is not based on total bronchospasm, but on pulmonary edema with damage to the pulmonary endothelium by immune complexes and biologically active substances (histamine, serotonin, slow-reacting substance of anaphylaxis, allergens, etc.) formed during type 1 allergic reactions.
Inhalation of toxic aerosols, industrial gases, as well as fumes generated in large quantities during a fire, immediately causes a paroxysmal cough, a feeling of rawness in the nasopharynx, and laryngo-bronchospasm may be observed. After the termination of contact (leaving the contaminated area or from the premises, putting on a gas mask), a period of imaginary well-being begins, which can last several hours, and when inhaling fumes - up to 2-3 days.
However, in the future, the condition of the victim deteriorates sharply: cough intensifies, dyspnea increases in intensity, clinical manifestations of expanded pulmonary edema are noted. When inhaled nitrogen dioxide in high concentrations, methemoglobinemia develops simultaneously with pulmonary edema. When the victim is in the fire zone, along with fumes and toxic products of incomplete combustion, carbon monoxide enters the lungs, which leads to a significant increase in the level of carboxyhemoglobin in the blood.
Such changes lead to significant disturbances in gas exchange and oxygen transport, and therefore the degree of oxygen starvation of tissues in adult respiratory distress syndrome increases significantly.
Treatment
The effectiveness of the treatment of toxic pulmonary edema largely depends on the speed of its recognition and the timely initiation of adequate therapy. Despite the fact that ARDS and hemodynamic pulmonary edema are based on fundamentally different pathogenetic mechanisms, doctors often consider them as a single symptom complex and carry out the same type of treatment of these fundamentally different conditions.The patient is prescribed drugs that reduce hydrostatic pressure in the pulmonary capillaries (peripheral vasodilators, diuretics and cardiac glycosides), which adversely affects his condition. In this regard, it is important to distinguish between hemodynamic and toxic pulmonary edema.
The diagnosis of the latter is carried out on the basis of the following criteria:
1) the development of acute respiratory failure against the background of a disease or pathological condition, accompanied by the phenomena of endotoxicosis or exposure to the lungs of toxic substances;
2) clinical and radiological manifestations of the interstitial or intraalveolar stage of pulmonary edema;
3) the course of pulmonary edema against the background of normal central venous pressure and pulmonary capillary wedge pressure, normal borders of cardiac dullness and the absence of effusion in the pleural cavities (if there are no severe concomitant diseases of the heart and lungs).
Having established the diagnosis of ARDS, you should immediately begin active complex therapy: treatment of the underlying disease and relief of toxic pulmonary edema. The main direction in the treatment of toxic pulmonary edema is the use of a set of drugs and therapeutic measures in order to normalize the impaired permeability of the alveolar-capillary membrane and prevent its further damage.
Currently, the drugs of choice in the prevention and treatment of toxic pulmonary edema of various nature are glucocorticoid drugs, which, due to the variety of mechanisms of action (anti-inflammatory, reduced histamine production, increased metabolism, etc.), reduce the initially high permeability of the alveolar membrane.
Prednisolone is usually administered up to 1.2-2 g per day intravenously (repeated intravenous bolus injections every 2-3 hours). At the same time, it is necessary to carry out short courses of treatment with glucocorticoid drugs (no more than 24-48 hours), since with a longer use they significantly increase the risk of secondary, often fatal pulmonary purulent-inflammatory complications.
It is justified, especially in the case of the development of adult respiratory distress syndrome when inhaling fumes and toxic substances, inhalation of glucocorticoids in high doses according to the following method: 4-5 inhalations of a metered-dose aerosol of auxilozone (dexamethasone isonicotinate) or becotide (becometasone dipropionate) every 10 minutes until the metered-dose inhaler is completely empty, designed for 200-2 50 doses.
Due to their sufficient effectiveness in these situations in a number of European countries, the equipment of rescue teams and firefighters includes the drug "Auxiloson" (firm "Thomae", Germany) in an individual package. It is used to provide self- and mutual assistance when the victim is in a contaminated atmosphere, and even more so when the first symptoms of toxic pulmonary edema develop.
The most important pathogenetic direction in the treatment of ARDS is adequate oxygen therapy. It begins with inhalation of 100% humidified oxygen through a nasal catheter (6-10 l/min), creating a positive end-expiratory pressure, which increases lung compliance and straightens atelectatic areas. With an increase in the phenomena of hypoxemia (partial pressure of oxygen less than 50 mm Hg), it is necessary to transfer the patient to artificial ventilation of the lungs.
Treatment for toxic pulmonary edema includes infusion therapy. In order to direct the flow of fluid from the interstitium into the lumen of the vessel by increasing the oncotic pressure of the blood, it is necessary to create an excess gradient. For this purpose, 200-400 ml of a 10-20% albumin solution is re-introduced per day. In case of ARDS due to endotoxicosis, detoxification therapy by extraorganic detoxification methods (hemofiltration, hemosorption, plasmapheresis) is mandatory.
The high efficiency of repeated hemofiltration sessions is due not only to the convertible transfer of large amounts of medium molecules involved in the formation of endotoxicosis and vascular permeability disorders, but also to the removal of excess extravascular fluid. The treatment program also includes the use of heparin in low doses (10,000-20,000 units per day subcutaneously), which helps prevent the progression of hemocoagulation disorders in the vessels of the lungs, and protease inhibitors (kontrykal, Gordox), blocking plasma and leukocyte proteolysis.
It is difficult and ambiguous to resolve the issue of antibiotic therapy tactics in patients with adult respiratory distress syndrome that occurs with endotoxicosis of infectious origin, since without adequate use of antibacterial drugs it is impossible to stop the infectious process. However, active therapy with properly selected antibacterial agents naturally leads to the destruction of microorganisms, increasing toxemia due to the release of large amounts of endotoxins. This contributes to the progression (development) of infectious-toxic shock and toxic pulmonary edema.
There are frequent cases when the development of toxic pulmonary edema coincides with the beginning of antibiotic therapy, which is especially typical for patients with severe forms of leptospirosis. In addition, it should be taken into account that in ARDS, in contrast to hemodynamic pulmonary edema, fluid with a high protein content accumulates in the alveoli, which is a favorable environment for the reproduction of microflora.
All this forces the use of antibacterial drugs in average therapeutic doses in the treatment of patients with toxic pulmonary edema. At the same time, as practice shows, in cases of development of ARDS at the height of infectious-toxic shock with leptospirosis, sepsis and meningococcal infection, it is necessary to temporarily (at least until stabilization of hemodynamic parameters) significantly reduce single doses of antibiotics.
Unlike hemodynamic pulmonary edema, in which, after the introduction of peripheral vasodilators and diuretics, the patient's condition almost immediately improves in most cases, treatment of toxic edema is a rather difficult task due to the variety of pathogenetic mechanisms and the lack of effective methods (drugs) to prevent the development and stop the violation of the permeability of the alveolar-capillary membrane.
The most difficult to treat is toxic pulmonary edema, which develops in a patient with multiple organ failure of various nature (against the background of sepsis or peritonitis). All this leads to a high incidence of deaths in these difficult clinical situations and requires further development of approaches to the treatment of toxic pulmonary edema.
V.G. Alekseev, V.N. Yakovlev
Pulmonary edema
A characteristic form of damage by pulmonotoxicants is pulmonary edema. The essence of the pathological condition is the release of blood plasma into the wall of the alveoli, and then into the lumen of the alveoli and the respiratory tract. Edematous fluid fills the lungs - a condition develops, previously referred to as "drowning on land."
Pulmonary edema is a manifestation of a violation of the water balance in the lung tissue (the ratio of the fluid content inside the vessels, in the interstitial space and inside the alveoli). Normally, blood flow to the lungs is balanced by its outflow through the venous and lymphatic vessels (the rate of lymphatic drainage is about 7 ml/hour).
The water balance of fluid in the lungs is provided by:
Regulation of pressure in the pulmonary circulation (normally 7-9 mm Hg; critical pressure - more than 30 mm Hg; blood flow rate - 2.1 l / min).
The barrier functions of the alveolar-capillary membrane, which separates the air in the alveoli from the blood flowing through the capillaries.
Pulmonary edema can occur as a result of a violation of both regulatory mechanisms, and each separately.
In this regard, there are three types of pulmonary edema:
- toxic pulmonary edema, developing as a result of a primary lesion of the alveolar-capillary membrane, against the background of normal, in the initial period, pressure in the pulmonary circulation;
- hemodynamic pulmonary edema, which is based on an increase in blood pressure in the pulmonary circulation, due to toxic damage to the myocardium and a violation of its contractility;
- mixed pulmonary edema when the victims have both a violation of the properties of the alveolar-capillary barrier and the myocardium.
The main toxicants causing the formation of pulmonary edema of various types are presented in Table 4.
Actually toxic pulmonary edema is associated with damage by toxicants to cells involved in the formation of the alveolar-capillary barrier. Military-grade toxicants capable of causing toxic pulmonary edema are called asphyxiant HIT.
The mechanism of damage to lung tissue cells by asphyxiating OVTV is not the same (see below), but the processes that develop after that are quite close.
Damage to cells and their death leads to an increase in the permeability of the barrier and disruption of the metabolism of biologically active substances in the lungs. The permeability of the capillary and alveolar parts of the barrier does not change simultaneously. Initially, the permeability of the endothelial layer increases, and the vascular fluid leaks into the interstitium, where it temporarily accumulates. This phase of development of pulmonary edema is called interstitial. During the interstitial phase, it is compensatory, about 10 times faster lymph flow. However, this adaptive reaction is insufficient, and the edematous fluid gradually penetrates through the layer of destructively altered alveolar cells into the cavities of the alveoli, filling them. This phase of the development of pulmonary edema is called alveolar and is characterized by the appearance of distinct clinical signs. “Switching off” part of the alveoli from the process of gas exchange is compensated by stretching of intact alveoli (emphysema), which leads to mechanical compression of the capillaries of the lungs and lymphatic vessels.
Cell damage is accompanied by the accumulation of biologically active substances such as norepinephrine, acetylcholine, serotonin, histamine, angiotensin I, prostaglandins E1, E2, F2, kinins in the lung tissue, which leads to an additional increase in the permeability of the alveolar-capillary barrier, impaired hemodynamics in the lungs. The rate of blood flow decreases, the pressure in the pulmonary circulation increases.
The edema continues to progress, fluid fills the respiratory and terminal bronchioles, and due to the turbulent movement of air in the airways, foam is formed, stabilized by the washed-out alveolar surfactant. In addition to these changes, for the development of pulmonary edema, systemic disorders are of great importance, which are included in the pathological process and intensify as it develops. Among the most important are: violations of the gas composition of the blood (hypoxia, hyper- and then hypocarbia), changes in the cellular composition and rheological properties (viscosity, clotting ability) of the blood, hemodynamic disorders in the systemic circulation, impaired renal function and central nervous system.
Characteristics of hypoxia
The main cause of disorders of many functions of the body in case of poisoning with pulmonotoxicants is oxygen starvation. So, against the background of developing toxic pulmonary edema, the oxygen content in arterial blood decreases to 12 vol.% or less, at a rate of 18-20 vol.%, venous - up to 5-7 vol.%, at a rate of 12-13 vol.%. The CO2 tension in the first hours of the development of the process increases (more than 40 mm Hg). In the future, as the pathology develops, hypercapnia is replaced by hypocarbia. The occurrence of hypocarbia can be explained by a violation of metabolic processes under hypoxic conditions, a decrease in CO2 production and the ability of carbon dioxide to easily diffuse through the edematous fluid. The content of organic acids in the blood plasma at the same time increases to 24-30 mmol/l (at a rate of 10-14 mmol/l).
Already in the early stages of the development of toxic pulmonary edema, the excitability of the vagus nerve increases. This leads to the fact that a smaller, compared to normal, stretching of the alveoli during inhalation serves as a signal to stop inhalation and start exhalation (Hering-Breuer reflex). At the same time, breathing becomes more frequent, but its depth decreases, which leads to a decrease in alveolar ventilation. The release of carbon dioxide from the body and the supply of oxygen to the blood are reduced - hypoxemia occurs.
A decrease in the partial pressure of oxygen and a slight increase in the partial pressure of CO2 in the blood leads to a further increase in dyspnea (a reaction from the vascular reflex zones), but, despite its compensatory nature, hypoxemia not only does not decrease, but, on the contrary, increases. The reason for the phenomenon is that although in conditions of reflex shortness of breath the minute volume of breathing is preserved (9000 ml), alveolar ventilation is reduced.
So, under normal conditions, at a respiratory rate of 18 per minute, alveolar ventilation is 6300 ml. Tidal volume (9000 ml: 18) - 500 ml. Dead space volume - 150 ml. Alveolar ventilation: 350 ml x 18 = 6300 ml. With an increase in breathing to 45 and the same minute volume (9000), the tidal volume decreases to 200 ml (9000 ml: 45). Only 50 ml of air (200 ml -150 ml) enters the alveoli with each breath. Alveolar ventilation per minute is: 50 ml x 45 = 2250 ml, i.e. decreases by about 3 times.
With the development of pulmonary edema, oxygen deficiency increases. This is facilitated by an ever-increasing violation of gas exchange (difficulty in the diffusion of oxygen through an increasing layer of edematous fluid), and in severe cases - a hemodynamic disorder (up to collapse). Developing metabolic disorders (decrease in the partial pressure of CO2, acidosis, due to the accumulation of incompletely oxidized metabolic products) impair the process of oxygen utilization by tissues.
Thus, the oxygen starvation that develops when affected by asphyxiating substances can be characterized as a mixed type of hypoxia: hypoxic (impaired external respiration), circulatory (disturbance of hemodynamics), tissue (disturbance of tissue respiration).
Hypoxia underlies severe disorders of energy metabolism. At the same time, organs and tissues with a high level of energy consumption (nervous system, myocardium, kidneys, lungs) suffer the most. Violations on the part of these organs and systems underlie the clinic of intoxication with asphyxiating OVTV.
Violation of the composition of peripheral blood
Significant changes in pulmonary edema are observed in peripheral blood. As edema increases and vascular fluid enters the extravascular space, the content of hemoglobin increases (at the height of edema, it reaches 200–230 g/l) and erythrocytes (up to 7–9.1012/l), which can be explained not only by thickening of the blood, but also by the release of formed elements from the depot (one of the compensatory reactions to hypoxia). The number of leukocytes increases (9-11.109/l). Significantly accelerated blood clotting time (30-60 s instead of 150 s under normal conditions). This leads to the fact that the affected have a tendency to thrombosis, and in case of severe poisoning, intravital blood clotting is observed.
Hypoxemia and thickening of the blood exacerbate hemodynamic disturbances.
Violation of the activity of the cardiovascular system
The cardiovascular system, along with the respiratory system, undergoes the most severe changes. Already in the early period develops bradycardia (excitation of the vagus nerve). As hypoxemia and hypercapnia increase, tachycardia develops and the tone of peripheral vessels increases (compensation reaction). However, with a further increase in hypoxia and acidosis, the contractility of the myocardium decreases, the capillaries expand, and blood is deposited in them. Blood pressure drops. At the same time, the permeability of the vascular wall increases, which leads to tissue edema.
Violation of the nervous system
The role of the nervous system in the development of toxic pulmonary edema is very significant.
The direct effect of toxic substances on the receptors of the respiratory tract and lung parenchyma, on the chemoreceptors of the pulmonary circulation can be the cause of the neuro-reflex impairment of the permeability of the alveolar-capillary barrier. The dynamics of the development of pulmonary edema is somewhat different when affected by various substances of asphyxiating action. Substances with a pronounced irritant effect (chlorine, chloropicrin, etc.) cause a more rapidly developing process than substances that practically do not cause irritation (phosgene, diphosgene, etc.). Some researchers refer to substances of "fast action" mainly those that damage mainly the alveolar epithelium, "slow action" - affecting the endothelium of the capillaries of the lungs.
Usually (with phosgene intoxication), pulmonary edema reaches a maximum 16 to 20 hours after exposure. It stays at this level for a day or two. At the height of the edema, the death of the affected is observed. If death does not occur in this period, then from 3 to 4 days the reverse development of the process begins (liquid resorption by the lymphatic system, increased outflow with venous blood), and on days 5 to 7 the alveoli are completely freed from fluid. Mortality in this formidable pathological condition is usually 5-10%, and about 80% of the total number of deaths die in the first 3 days.
Complications of pulmonary edema are bacterial pneumonia, the formation of pulmonary infiltrate, thromboembolism of the main vessels.